Cetuximab, Docetaxel and Cisplatin as First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results of the GORTEC 2014-01 TPExtreme Randomized Trial - Concepedia

Concepedia

Publication | Open Access

Cetuximab, Docetaxel and Cisplatin as First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results of the GORTEC 2014-01 TPExtreme Randomized Trial

DOI Full Paper Access

12

Citations

0

References

2020

Year

J. Guigay, Anne Aupérin, Jérôme Fayette, Esma Saâda-Bouzid, Cédrik Lafond, Miren Taberna, Lionnel Geoffrois, Laurent Martin, Olivier Capitain, Didier Cupissol,

SSRN Electronic Journal

No additional data available for this publication yet. Check back later!